Effects of gemcitabine on cell survival and chromosome aberrations after pulsed low dose-rate irradiation

Journal of Radiation Research

Volumn 45, Issue 1, 2004, Pages 111-118

  Kreder, Natasja Castro ^a   Van Bree, Chris ^a   Franken, Nicolaas A P ^a   Haveman, Jaap ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Aberrations; Cell survival; Chromosome; Fragments; Gemcitabine; X irradiation

Indexed keywords

CELL CULTURE; DOSIMETRY; DRUG DOSAGE; FISH; IRRADIATION; RADIATION EFFECTS;

CELL SURVIVAL; ENHANCEMENT FACTOR; FLUORESCENT IN SITU HYBRIDIZATION; FRAGMENT; GEMCITABINE; HIGH DOSE RATE; LOW DOSE RATE IRRADIATION; LOW-DOSE RATES; RADIO-SENSITIZATION; X-IRRADIATION;

CHROMOSOMES;

GEMCITABINE;

ARTICLE; BIOASSAY; BRACHYTHERAPY; CANCER CELL CULTURE; CELL SURVIVAL; CHROMOSOME 18; CHROMOSOME 2; CHROMOSOME ABERRATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; DRUG POTENTIATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENOMICS; HUMAN; HUMAN CELL; INCUBATION TIME; LUNG CARCINOMA; PULSE RATE; RADIATION DOSE; RADIOSENSITIZATION; X IRRADIATION;

EID: 2542569598     PISSN: 04493060     EISSN: None     Source Type: Journal    
DOI: 10.1269/jrr.45.111     Document Type: Article

References (37)

1. Hall, E. J. (1972) Radiation dose-rate: a factor of importance in radiobiology and radiotherapy. Br. J. Radiol. 45: 81-97.
2. Mitchell, J. B., Bedford, J. S. and Bailey, S. M. (1979) Dose-rate effects on the cell cycle and survival of S3 HeLa and V79 cells. Radiat. Res. 79: 520-536.
3. Barendsen, G. W. (1982) Dose fractionation, dose rate and isoeffect relationships for normal tissue responses. Int. J. Radiat. Oncol. Biol. Phys. 8: 1981-1997.
4. Barendsen, G. W. (1997) Parameters of linear-quadratic radiation dose-effect relationships: dependence on LET and mechanisms of reproductive cell death. Int. J. Radiat. Biol. 71: 649-655.
5. Takatsuji, T., Yoshikawa, I. and Sasaki, M. S. (1999) Generalized concept of the LET-RBE relationship of radiation-induced chromosome aberration and cell death. J. Radiat. Res. (Tokyo) 40: 59-69.
6. Franken, N. A., Van Bree, C., Veltmaat, M. A., Rodermond, H. M., Haveman, J. and Barendsen, G. W. (2001) Radiosensitization by bromodeoxyuridine and hyperthermia: analysis of linear and quadratic parameters of radiation survival curves of two human tumor cell lines. J. Radiat. Res. (Tokyo) 42: 179-190.
7. Yamazaki, H., Inoue, T., Yoshida, K., Yoshioka, Y., Furukawa, S., Kakimoto, N., Shimizutani, K. and Inoue, T. (2003) Brachytherapy for early oral tongue cancer: low dose rate to high dose rate. J. Radiat. Res. (Tokyo) 44: 37-40.
8. Hertel, L. W., Boder, G. B., Kroin, J. S., Rinzel, S. M., Poore, G. A., Todd, G. C. and Grindey G. B. (1990) Evaluation of the antitumor activity of gemcitabine (2′,2′-difluoro-2′-deoxycytidine). Cancer Res. 50: 4417-4422.
9. Heinemann, V., Hertel, L. W., Grindey, G. B. and Plunkett, W. (1988) Comparison of the cellular pharmacokinetics and toxicity of 2′, 2′difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine. Cancer Res. 48: 4024-4031.
10. Haveman, J., Rietbroek, R. C., Geerdink, A., Van Rijn, J. and Bakker, P. J. (1995) Effect of hyperthermia on the cytotoxicity of 2′,2′- difluorodeoxycytidine (gemcitabine) in cultured SW1573 cells. Int. J. Cancer 62: 627-630.
11. Plunkett, W., Huang, P. and Gandhi, V. (1995) Preclinical characteristics of gemcitabine. Anticancer Drugs 6: 6-7.
12. Ruiz van Haperen, V. and Peters, G. J. (1994) New targets for pyrimidine antimetabolites for the treatment of solid tumours. 2: 16-104.
13. Van Moorsel, C. J., Bergman, A. M., Veerman, G., Voorn, D. A., Ruiz van Haperen, V., Kroep, J. R., Pinedo, H. M. and Peters, G. J. (2000) Differential effects of gemcitabine on ribonucleotide pools of twenty-one solid tumour and leukaemia cell lines. Biochim. Biophys. Acta. 1474: 5-12.
14. Rockwell, S. and Grindey, G. B. (1992) Effect of 2′,2′- difluorodeoxycytidine on the viability and radiosensitivity of EMT6 cells in vitro. Oncol. Res. 4: 151-155.
15. Shewach, D. S., Hahn, T. M., Chang, E., Hertel, L. W. and Lawrence, T. S. (1994) Metabolism of 2′,2′-difluoro-2′-deoxycytidine and radiation sensitization of human colon carcinoma cells. Cancer Res. 54: 3218-3223.
16. Latz, D., Fleckenstein, K., Eble, M., Blatter, J., Wannenmacher, M. and Weber, K. J. (1998) Radiosensitizing potential of gemcitabine (2′,2′-difluoro-2′-deoxycytidine) within the cell cycle in vitro. Int. J. Radiat. Oncol. Biol. Phys. 41: 875-882.
17. Lawrence, T. S., Chang, E. Y., Hahn, T. M., Hertel, L. W. and Shewach, D. S. (1996) Radiosensitization of pancreatic cancer cells by 2′,2′- difluoro-2′-deoxycytidine. Int. J. Radiat. Oncol. Biol. Phys. 34: 867-872.
18. Rosier, J. F., Beauduin, M., Bruniaux, M., De Bast, M., De Coster, B., Octave-Prignot, M., Scalliet, P. and Gregoire, V. (1999) The effect of 2′-2′ difluorodeoxycytidine (dFdC, gemcitabine) on radiation-induced cell lethality in two human head and neck squamous carcinoma cell lines differing in intrinsic radiosensitivity. Int. J. Radiat. Biol. 75: 245-251.
19. Van Bree, C., Castro Kreder, N., Loves, W. J., Franken, N. A., Peters, G. J. and Haveman, J. (2002) Sensitivity to ionizing radiation and chemotherapeutic agents in gemcitabine-resistant human tumor cell lines. Int. J. Radiat. Oncol. Biol. Phys. 54: 237-244.
20. Castro Kreder, N., Van Bree, C., Franken, N. A. and Haveman, J. (2003) Colour junctions as predictors of radiosensitivity: X-irradiation combined with gemcitabine in a lung carcinoma cell line. J. Cancer Res. Clin. Oncol. 129: 597-603.
21. Ofuchi, T., Suzuki, M., Kase, Y., Ando, K., Isono, K. and Ochiai, T. (1999) Chromosome breakage and cell lethality in human hepatoma cells irradiated with X rays and carbon-ion beams. J. Radiat. Res. (Tokyo) 40: 125-133.
22. Ritter, S., Nasonova, E., Furusawa, Y. and Ando K. (2002) Relationship between aberration yield and mitotic delay in human lymphocytes exposed to 200 MeV/u Fe-ions or X-rays. J. Radiat. Res. (Tokyo) 43: 175-179.
23. Rosier, J. F., Michaux, L., Ameye, G., Cedervall, B., Libouton, J. M., Octave-Prignot, M., Verellen-Dumoulin, C., Scalliet, P. and Gregoire, V. (2003) The radioenhancement of two human head and neck squamous cell carcinomas by 2′-2′ difluorodeoxycytidine (gemcitabine; dFdC) is mediated by an increase in radiation-induced residual chromosome aberrations but not residual DNA DSBs. Mutat. Res. 527: 15-26.
24. Castro Kreder, N., Van Bree, C., Franken, N. A. and Haveman, J. (2002) Chromosome aberrations detected by FISH and correlation with cell survival after irradiation at various dose-rates and after bromodeoxyuridine radiosensitization. Int. J. Radiat. Biol. 78: 203-210.
25. Pinkel, D., Straume, T. and Gray, J. W. (1986) Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc. Natl. Acad. Sci. U.S.A. 83: 2934-2938.
26. Natarajan, A. T., Vyas, R. C., Darroudi, F. and Vermeulen. S. (1992) Frequencies of X-ray-induced chromosome translocations in human peripheral lymphocytes as detected by in situ hybridization using chromosome-specific DNA libraries. Int. J. Radiat. Biol. 61: 199-203.
27. Tucker, J. D., Morgan, W. F., Awa, A. A., Bauchinger, M., Blakey, D., Cornforth, M. N., Littlefield, L. G., Natarajan, A. T. and Shasserre, C. (1995) A proposed system for scoring structural aberrations detected by chromosome painting. Cytogenet. Cell Genet. 68: 211-221.
28. Coco-Martin, J. M., Ottenheim, C. P., Bartelink, H. and Begg, A. C. (1996) Lethality of radiation-induced chromosome aberrations in human tumour cell lines with different radiosensitivities. Int. J. Radiat. Biol. 69: 337-344.
29. Castro Kreder, N., Van Bree, C., Peters, G. J., Loves, W. J. P. and Haveman, J. (2002) Enhanced levels of deoxycytidine kinase and thymidine kinase 1 and 2 after pulsed low dose rate irradiation as an adaptive response to radiation. Oncol. Rep. 9: 141-144.
30. McGinn, C. J., Shewach, D. S. and Lawrence, T. S. (1996) Radiosensitizing nucleosides. J. Natl. Cancer Inst. 88: 1193-1203.
31. Natarajan, A. T., Balajee, A. S., Boei, J. J., Darroudi, F., Dominguez, I., Hande, M. P., Meijers, M., Slijepcevic, P., Vermeulen, S. and Xiao, Y. (1996) Mechanisms of induction of chromosomal aberrations and their detection by fluorescence in situ hybridization. Mutat. Res. 372: 247-258.
32. Franken, N. A., Ruurs, P., Ludwikow, G., Van Bree, C., Kipp, J. B., Darroudi, F. and Barendsen, G. W. (1999) Correlation between cell reproductive death and chromosome aberrations assessed by FISH for low and high doses of radiation and sensitization by iodo-deoxyuridine in human SW-1573 cells. Int. J. Radiat Biol. 75: 293-299.
33. Genç, M., Castro Kreder, N., Barten-van Rijbroek, A., Stalpers, L. J. A. and Haveman, J. (2004) Enhancement of effects of irradiation by gemcitabine in a glioblastoma cell line and cell line spheroids. J. Cancer Res. Clin. Oncol. 130: 45-51.
34. Weiss, C., Grabenbauer, G. G., Sauer, R. and Distel, L. (2003) Significant increase in residual DNA damage as a possible mechanism of radiosensitization by gemcitabine. Strahlenther Onkol. 179: 93-98.
35. Lawrence, T. S., Davis, M. A., Hough, A. and Rehemtulla, A. (2001) The role of apoptosis in 2′,2′-difluoro-2′-deoxycytidine (gemcitabine)-mediated radiosensitization. Clin. Cancer Res. 7: 314-319.
36. Ostruszka, L. J. and Shewach, D. S. (2000) The role of cell cycle progression in radiosensitization by 2′,2′-difluoro-2′- deoxycytidine. Cancer. Res. 60: 6080-6088.
37. Lawrence, T. S., Eisbruch, A. and Shewach, D. S. (1997) Gemcitabine-mediated radiosensitization. Semin. Oncol. 24: 2-7.